POSEIDA THERAPEUTICS
Poseida Therapeutics is a clinical-stage biopharmaceutical company utilizing genome engineering capabilities to develop targeted therapeutics for patients with high unmet medical needs. The company develops a pipeline of autologous and allogeneic chimeric antigen receptor T cell or CAR-T, product candidates focusing on the treatment of hematological malignancies and solid tumors.
POSEIDA THERAPEUTICS
Industry:
Biopharma Biotechnology Genetics Therapeutics
Founded:
2014-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.poseida.com
Total Employee:
251+
Status:
Active
Contact:
(858)-779-3100
Email Addresses:
[email protected]
Total Funding:
460.45 M USD
Technology used in webpage:
Domain Not Resolving IPv6 ReCAPTCHA ReCAPTCHA V2 Twitter Tweet Button Akamai Hosted
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
VintaBio
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Astellas Pharma
Astellas Pharma investment in Post-IPO Equity - Poseida Therapeutics
Schonfeld Strategic Advisors
Schonfeld Strategic Advisors investment in Series D - Poseida Therapeutics
Fidelity
Fidelity investment in Series D - Poseida Therapeutics
Adage Capital Management
Adage Capital Management investment in Series D - Poseida Therapeutics
Longitude Capital
Longitude Capital investment in Series C - Poseida Therapeutics
Malin Corporation
Malin Corporation investment in Series C - Poseida Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series C - Poseida Therapeutics
Boxer Capital
Boxer Capital investment in Series C - Poseida Therapeutics
Aisling Capital
Aisling Capital investment in Series C - Poseida Therapeutics
Pentwater Capital Management
Pentwater Capital Management investment in Series C - Poseida Therapeutics
Key Employee Changes
Official Site Inspections
http://www.poseida.com Semrush global rank: 2.86 M Semrush visits lastest month: 5.82 K
- Host name: 204.96.230.35.bc.googleusercontent.com
- IP address: 35.230.96.204
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Poseida Therapeutics"
About Us - Poseida Therapeutics
Poseida Therapeutics is a clinical-stage biopharmaceutical company developing innovative solutions to advance a new class of cell and gene therapies. Skip to content. MENU. CLOSE. …See details»
Poseida Therapeutics - Crunchbase Company Profile
Poseida Therapeutics is a clinical-stage biopharmaceutical company utilizing genome engineering capabilities to develop targeted therapeutics for patients with high unmet medical needs. The company develops a pipeline of autologous …See details»
Contact Us - Poseida Therapeutics
Poseida Therapeutics, Inc. 9390 Towne Centre Drive Suite 200 San Diego, CA 92121. 858.779.3100. [email protected]. Investor and Media Contact. Sarah Thailing Senior Director, Corporate Communications & IR. 858.605.3717.See details»
Poseida Therapeutics, Inc. - Most Loved Workplace®
Poseida Therapeutics, Inc. has been chosen as a 2023 Top 100 Most Loved Workplace® in Newsweek. Most Loved Workplaces® place love at center of business ... Our organization is …See details»
Poseida Therapeutics - Company Profile - Tracxn
Dec 13, 2024 Poseida Therapeutics - Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies. Acquired by Roche. Raised a total funding …See details»
Poseida Therapeutics Mission, Benefits, and Work Culture - Indeed
The organization is comprised of passionate, innovative, and nimble, results-oriented people driven by science to develop better options for patients with cancer and genetic diseases. ...See details»
Corporate Presentation - investors.poseida.com
Poseida tools designed to work together as a system T SCM correlates with depth and durability of response Non-viral gene insertion system Transposon 1 Gene editing system Cas-CLOVER …See details»
Poseida Therapeutics - Contacts, Employees, Board Members
Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics. Search Crunchbase Start Free TrialSee details»
Poseida Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
Poseida Therapeutics is a clinical-stage biotechnology company translating best-in-class technology into life-saving cell and gene therapies for patients with high unmet medical needs. …See details»
Poseida Therapeutics, Inc. Announces Agreement to be Acquired …
Nov 26, 2024 Poseida stockholders to receive up to $13.00 per share in cash, comprised of $9.00 per share in cash at closing and a non-tradeable contingent value right (CVR) to receive …See details»
Roche enters into a definitive agreement to acquire Poseida
Nov 26, 2024 About Poseida Poseida Therapeutics is a clinical-stage biopharmaceutical company advancing differentiated allogeneic cell therapies and genetic medicines with the …See details»
Poseida Therapeutics - Overview, News & Similar companies
Jun 3, 2024 Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders SAN DIEGO, June 3, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a …See details»
Poseida’s Competitors, Revenue, Number of Employees, Funding …
Poseida’s Profile, Revenue and Employees. Poseida is a California-based biopharmaceutical company that researches and develops gene therapies for the treatment of cancer and genetic …See details»
SEC Filing - Poseida Therapeutics, Inc.
Feb 8, 2024 We have acted as counsel to Poseida Therapeutics, Inc., a Delaware corporation (the “Company”), in connection with the filing by the Company of a Registration Statement on …See details»
Working at Poseida Therapeutics: 12 Reviews - Indeed
Oct 30, 2024 Poseida is a very fast paced and collaborative environment. Communication is pretty thorough between operations management and the manufacturing team. At all levels …See details»
Careers & Culture - Poseida Therapeutics
Poseida Therapeutics, Inc. has received reports of employment-related scams. These scams have appeared in forms of false job advertisements and/or unsolicited contacts via …See details»
Form SC 13G for Poseida Therapeutics INC filed 11/08/2024
Poseida Therapeutics, Inc. ----- (Name of Issuer) Common Stock ... Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) …See details»
Astellas and Poseida Therapeutics Announce Strategic Investment …
Poseida is a clinical-stage biotechnology company dedicated to advancing a new class of cancer cell therapy and gene therapy products using genetic engineering technologies Astellas to …See details»
Publications - Poseida Therapeutics
Read the latest publications, research, and presentations on Poseida’s science. Scientific Publications. Cas-CLOVER is a novel high-fidelity nuclease for safe and robust generation of …See details»